dc.contributor.author | Kamhi, E. | |
dc.contributor.author | Joo, E.J. | |
dc.contributor.author | Dordick, J.S. | |
dc.contributor.author | Linhardt, Robert J. | |
dc.date | 2013 | |
dc.date.accessioned | 2022-06-23T04:17:34Z | |
dc.date.available | 2022-06-23T04:17:34Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Glycosaminoglycans in infectious disease, E. Kamhi, E. J. Joo, J. S. Dordick, R. J. Linhardt, Biological Reviews, 88, 928–943, 2013. | |
dc.identifier.uri | https://hdl.handle.net/20.500.13015/5336 | |
dc.identifier.uri | https://doi.org/10.1111/brv.12034 | |
dc.description | Biological Reviews, 88, 928–943 | |
dc.description | Note : if this item contains full text it may be a preprint, author manuscript, or a Gold OA copy that permits redistribution with a license such as CC BY. The final version is available through the publisher’s platform. | |
dc.description.abstract | Glycosaminoglycans (GAGs) are complex carbohydrates that are ubiquitously present on the cell surface and in the extracellular matrix. Interactions between GAGs and pathogens represent the first line of contact between pathogen and host cell and are crucial to a pathogen's invasive potential. Their complexity and structural diversity allow GAGs to control a wide array of biological interactions influencing many physiological and pathological processes, including adhesion, cell-to-cell communication, biochemical cascades, and the immune response. In recent years, increasing evidence indicates an extraordinary role for GAGs in the pathogenesis of viruses, bacteria and parasites. Herein, we examine the interface between GAGs and different pathogens, and address the divergent biological functions of GAGs in infectious disease. We consider approaches to use this understanding to design novel therapeutic strategies addressing new challenges in the treatment of infectious diseases. | |
dc.language | en_US | |
dc.language.iso | ENG | |
dc.publisher | Wiley | |
dc.relation.ispartof | The Linhardt Research Labs Online Collection | |
dc.relation.ispartof | Rensselaer Polytechnic Institute, Troy, NY | |
dc.relation.uri | https://harc.rpi.edu/ | |
dc.subject | Biology | |
dc.subject | Chemistry and chemical biology | |
dc.subject | Chemical and biological engineering | |
dc.subject | Biomedical engineering | |
dc.title | Glycosaminoglycans in infectious disease | |
dc.type | Article | |
dcterms.accessRights | A full text version is available in DSpace@RPI | |
dcterms.isVersionOf | https://doi.org/10.1111/brv.12034 | |
dc.rights.holder | In Copyright : this Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). https://rightsstatements.org/page/InC/1.0/ | |
dc.creator.identifier | https://orcid.org/0000-0003-2219-5833 | |
dc.relation.department | The Linhardt Research Labs. | |
dc.relation.department | The Shirley Ann Jackson, Ph.D. Center for Biotechnology and Interdisciplinary Studies (CBIS) | |